Financhill
Back

Camurus AB Vs. Collegium Pharmaceutical Industry Stock Comparison

Sell
31

CAMRF
Camurus AB

Last Price:
$50.97
Seasonality Move:
111.6%
Sell
45

COLL
Collegium Pharmaceutical

Last Price:
$33.33
Seasonality Move:
-1.63%
Sell
31
Camurus AB (CAMRF) is a Sell

Is Camurus AB a Buy, Sell or Hold?

  • The current Camurus AB [CAMRF] share price is $50.97. The Score for CAMRF is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • CAMRF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Collegium Pharmaceutical (COLL) is a Sell

Is Collegium Pharmaceutical a Buy, Sell or Hold?

  • The current Collegium Pharmaceutical [COLL] share price is $33.34. The Score for COLL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • COLL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CAMRF Stock Price Chart

What is Camurus AB's stock price today?

  • The Camurus AB share price today is $50.97
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CAMRF is experiencing slight buying pressure.

COLL Stock Price Chart

What is Collegium Pharmaceutical's stock price today?

  • The Collegium Pharmaceutical share price today is $33.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and COLL is experiencing buying pressure, which is a positive indicator for future bullish movement.

CAMRF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.79 Sell
Relative Strength Index (14 RSI): 3.58 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.97 - 50.97) Sell
Bollinger Bands (100): (52.56 - 60.42) Sell

COLL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 66.05 Buy
Chaikin Money Flow: 1007158 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.9 - 30.94) Buy
Bollinger Bands (100): (30.52 - 37.92) Sell

CAMRF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.97 Sell
20-day SMA: 50.97 Sell
50-day SMA: 53.8 Sell
200-day SMA: 54.23 Sell
8-day EMA: 50.97 Sell
20-day EMA: 51.42 Sell
50-day EMA: 53.39 Sell
200-day EMA: 51.43 Sell

COLL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.45 Buy
20-day SMA: 29.79 Buy
50-day SMA: 30.91 Buy
200-day SMA: 34.47 Sell
8-day EMA: 30.02 Buy
20-day EMA: 29.94 Buy
50-day EMA: 31.21 Buy
200-day EMA: 32.94 Buy

Camurus AB Earnings Growth & CAMRF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Collegium Pharmaceutical Earnings Growth & COLL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $0.51 per share.

Camurus AB Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Collegium Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):